A detailed history of Pictet Asset Management Sa transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Pictet Asset Management Sa holds 941,773 shares of IMCR stock, worth $29.8 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
941,773
Previous 888,951 5.94%
Holding current value
$29.8 Million
Previous $43.9 Million 28.49%
% of portfolio
0.07%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$48.54 - $61.64 $2.56 Million - $3.26 Million
52,822 Added 5.94%
941,773 $56.5 Million
Q1 2023

May 10, 2023

BUY
$46.12 - $65.71 $12.5 Million - $17.8 Million
270,636 Added 43.77%
888,951 $43.9 Million
Q4 2022

Feb 13, 2023

BUY
$45.51 - $65.08 $28.1 Million - $40.2 Million
618,315 New
618,315 $35.3 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.39B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.